Who Holds Cellectar Biosciences, Inc. (CLRB)? 29 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 29 holders, $9 million in total.
Largest holders
The 29 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Caligan Partners LP | 469,998 | $1 million | New | 13F |
| STEMPOINT CAPITAL LP | 354,938 | $986,728 | New | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 327,367 | $910,080 | +300% | 13F |
| SILVERARC CAPITAL MANAGEMENT, LLC | 321,728 | $894,404 | New | 13F |
| Bleichroeder LP | 288,679 | $802,528 | +189% | 13F |
| Jupiter Topco LLC | 274,156 | $759,412 | New | 13F |
| Balyasny Asset Management L.P. | 220,000 | $611,600 | New | 13F |
| Nantahala Capital Management, LLC | 219,998 | $611,594 | New | 13F |
| Empery Asset Management, LP | 189,605 | $527,102 | New | 13F |
| DIADEMA PARTNERS LP | 138,341 | $384,588 | New | 13F |
| Stonepine Capital Management, LLC | 104,550 | $290,649 | New | 13F |
| Persistent Asset Partners Ltd | 92,983 | $258,493 | New | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 85,069 | $236,492 | New | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 53,351 | $148,323 | +1% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 46,220 | $128,492 | +179% | 13F |
| Sequoia Financial Advisors, LLC | 21,850 | $60,743 | +16% | 13F |
| Riverview Capital Advisers, LLC | 10,384 | $50,051 | +0% | 13F |
| NORTHERN TRUST CORP | 14,839 | $41,252 | New | 13F |
| BlackRock, Inc. | 4,735 | $13,163 | 0% | 13F |
| UBS Group AG | 3,093 | $8,599 | -68% | 13F |
| BARCLAYS PLC | 561 | $1,560 | New | 13F |
| MORGAN STANLEY | 510 | $1,418 | +0% | 13F |
| TD Waterhouse Canada Inc. | 63 | $178 | +0% | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 16,577 | $46 | New | 13F |
| SBI Securities Co., Ltd. | 11 | $31 | +0% | 13F |
| OSAIC HOLDINGS, INC. | 7 | $18 | +600% | 13F |
| US BANCORP \DE\ | 3 | $8 | +0% | 13F |
| JONES FINANCIAL COMPANIES LLLP | 3 | $8 | +0% | 13F |
| DANSKE BANK A/S | 2 | $6 | +0% | 13F |
Questions and answers
- How many institutions hold Cellectar Biosciences, Inc.?
- 29 managers reported Cellectar Biosciences, Inc. on Form 13F for the quarter ended 30 June 2026, against 19 the quarter before.
- Who is the largest institutional holder of Cellectar Biosciences, Inc.?
- Caligan Partners LP, with 469,998 shares worth $1 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Cellectar Biosciences, Inc. in Q2 2026?
- 14 managers reported a new position and 4 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Cellectar Biosciences, Inc., Q2 2026", https://app.tamarly.ai/holders/cellectar-biosciences, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.